Published in Hum Mol Genet on November 26, 2008
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias. J Clin Invest (2010) 1.73
Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice. J Clin Invest (2010) 1.67
Cranial neural crest cells on the move: their roles in craniofacial development. Am J Med Genet A (2010) 1.55
Identification of a Van der Woude syndrome mutation in the cleft palate 1 mutant mouse. Genesis (2010) 1.48
Integration of IRF6 and Jagged2 signalling is essential for controlling palatal adhesion and fusion competence. Hum Mol Genet (2009) 1.45
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas. Proc Natl Acad Sci U S A (2011) 1.42
Genetics of nonsyndromic orofacial clefts. Cleft Palate Craniofac J (2011) 1.27
Comparative analysis of IRF6 variants in families with Van der Woude syndrome and popliteal pterygium syndrome using public whole-exome databases. Genet Med (2012) 1.10
Interferon regulatory factor 6 promotes differentiation of the periderm by activating expression of Grainyhead-like 3. J Invest Dermatol (2012) 1.09
Smad4-Irf6 genetic interaction and TGFβ-mediated IRF6 signaling cascade are crucial for palatal fusion in mice. Development (2013) 1.03
Palatogenesis: engineering, pathways and pathologies. Organogenesis (2011) 1.03
Periderm prevents pathological epithelial adhesions during embryogenesis. J Clin Invest (2014) 0.91
Search for genetic modifiers of IRF6 and genotype-phenotype correlations in Van der Woude and popliteal pterygium syndromes. Am J Med Genet A (2013) 0.91
Genetics and management of the patient with orofacial cleft. Plast Surg Int (2012) 0.89
A symphony of regulations centered on p63 to control development of ectoderm-derived structures. J Biomed Biotechnol (2011) 0.86
Toward an orofacial gene regulatory network. Dev Dyn (2015) 0.85
De novo 2.3 Mb microdeletion of 1q32.2 involving the Van der Woude Syndrome locus. Mol Cytogenet (2013) 0.83
Van der Woude syndrome- a syndromic form of orofacial clefting. J Clin Exp Dent (2012) 0.83
Genomic strategy identifies a missense mutation in WD-repeat domain 65 (WDR65) in an individual with Van der Woude syndrome. Am J Med Genet A (2011) 0.83
p63 and IRF6: brothers in arms against cleft palate. J Clin Invest (2010) 0.82
Intra-amniotic transient transduction of the periderm with a viral vector encoding TGFβ3 prevents cleft palate in Tgfβ3(-/-) mouse embryos. Mol Ther (2012) 0.80
IRF6 is the mediator of TGFβ3 during regulation of the epithelial mesenchymal transition and palatal fusion. Sci Rep (2015) 0.78
IRF6 polymorphisms in Mexican patients with non-syndromic cleft lip. Meta Gene (2015) 0.76
Van der Woude syndrome: a review of 11 cases seen at the Lagos University Teaching Hospital. Afr J Paediatr Surg (2014) 0.75
A Japanese family with popliteal pterygium syndrome. Case Reports Plast Surg Hand Surg (2015) 0.75
Disrupted IRF6-NME1/2 Complexes as a Cause of Cleft Lip/Palate. J Dent Res (2017) 0.75
Genetic analysis of IRF6, a gene involved in craniofacial midline formation, in relation to pituitary and facial morphology of patients with idiopathic growth hormone deficiency. Pituitary (2017) 0.75
WebLogo: a sequence logo generator. Genome Res (2004) 59.58
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (1994) 26.02
DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res (2004) 8.63
IRF family of transcription factors as regulators of host defense. Annu Rev Immunol (2001) 8.18
Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate. N Engl J Med (2004) 7.91
Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet (2002) 6.29
Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet (2003) 4.44
Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip. Nat Genet (2008) 4.04
Fistula labii inferioris congenita and its association with cleft lip and palate. Am J Hum Genet (1954) 3.38
MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans. Nat Genet (2000) 3.35
Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature (1996) 3.27
Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat Genet (2006) 3.14
Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature (1996) 2.98
Impaired FGF signaling contributes to cleft lip and palate. Proc Natl Acad Sci U S A (2007) 2.94
Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol Cell Biol (1999) 2.93
Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate. J Med Genet (2003) 2.72
Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch. Nat Genet (2006) 2.68
Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol (1993) 2.51
Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature (1998) 2.48
The T-box transcription factor gene TBX22 is mutated in X-linked cleft palate and ankyloglossia. Nat Genet (2001) 2.46
Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev (1996) 2.43
Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia. Nat Genet (2000) 2.39
Incidence of cleft lip, cleft palate, and cleft lip and palate among races: a review. Cleft Palate J (1987) 2.38
Clinical and epidemiologic studies of cleft lip and palate in the Philippines. Cleft Palate Craniofac J (1997) 2.33
Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat Struct Biol (2003) 1.80
Cell autonomous requirement for Tgfbr2 in the disappearance of medial edge epithelium during palatal fusion. Dev Biol (2006) 1.79
Developmental expression analysis of the mouse and chick orthologues of IRF6: the gene mutated in Van der Woude syndrome. Dev Dyn (2006) 1.79
Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences. EMBO J (1999) 1.77
Evidence of a locus for orofacial clefting on human chromosome 6p24 and STS content map of the region. Hum Mol Genet (1995) 1.75
Mutation of PVRL1 is associated with sporadic, non-syndromic cleft lip/palate in northern Venezuela. Nat Genet (2001) 1.67
Crystal structure of PU.1/IRF-4/DNA ternary complex. Mol Cell (2002) 1.64
Genetic variants in IRF6 and the risk of facial clefts: single-marker and haplotype-based analyses in a population-based case-control study of facial clefts in Norway. Genet Epidemiol (2008) 1.63
Etiology of facial clefts: prospective evaluation of 428 patients. Cleft Palate J (1988) 1.61
Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J (1999) 1.56
Lip pits and deletion 1q32----41. Am J Med Genet (1987) 1.49
Linkage of an autosomal dominant clefting syndrome (Van der Woude) to loci on chromosome Iq. Am J Hum Genet (1990) 1.48
Popliteal pterygium syndrome. J Med Genet (1990) 1.43
In a Vietnamese population, MSX1 variants contribute to cleft lip and palate. Genet Med (2004) 1.39
The ETS-domain transcription factors Elk-1 and SAP-1 exhibit differential DNA binding specificities. Nucleic Acids Res (1995) 1.31
TBX22 mutations are a frequent cause of cleft palate. J Med Genet (2004) 1.30
Popliteal pterygium syndrome: a clinical study of three families and report of linkage to the Van der Woude syndrome locus on 1q32. J Med Genet (1999) 1.28
Microdeletions at chromosome bands 1q32-q41 as a cause of Van der Woude syndrome. Am J Med Genet (1999) 1.27
A preliminary gene map for the Van der Woude syndrome critical region derived from 900 kb of genomic sequence at 1q32-q41. Genome Res (2000) 1.26
Evidence for a microdeletion in 1q32-41 involving the gene responsible for Van der Woude syndrome. Hum Mol Genet (1994) 1.23
Interferon regulatory factor 6 promotes cell cycle arrest and is regulated by the proteasome in a cell cycle-dependent manner. Mol Cell Biol (2008) 1.22
Phenotypic variation in the popliteal pterygium syndrome. Clin Genet (1973) 1.21
Stereochemical punctuation marks in protein structures: glycine and proline containing helix stop signals. J Mol Biol (1998) 1.17
PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene. J Immunol (2001) 1.14
Further evidence for the involvement of human chromosome 6p24 in the aetiology of orofacial clefting. J Med Genet (1998) 1.10
Six families with van der Woude and/or popliteal pterygium syndrome: all with a mutation in the IRF6 gene. J Med Genet (2004) 1.09
Refinement of the Van der Woude gene location and construction of a 3.5-Mb YAC contig and STS map spanning the critical region in 1q32-q41. Genomics (1996) 0.93
Van Der Woude syndrome: variable penetrance of a novel mutation (p.Arg 84Gly) of the IRF6 gene in a Turkish family. Int J Mol Med (2005) 0.90
Mixed clefting type in Rapp-Hodgkin syndrome. Am J Med Genet (2002) 0.78
Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate. N Engl J Med (2004) 7.91
Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet (2002) 6.29
Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip. Nat Genet (2008) 4.04
Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat Med (2008) 3.53
Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat Genet (2006) 3.14
Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch. Nat Genet (2006) 2.68
Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet (2010) 2.52
Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities. Proc Natl Acad Sci U S A (2006) 2.39
The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor. Proc Natl Acad Sci U S A (2004) 2.27
Collagens at a glance. J Cell Sci (2007) 2.26
Rieske business: structure-function of Rieske non-heme oxygenases. Biochem Biophys Res Commun (2005) 2.24
Cleft palate: players, pathways, and pursuits. J Clin Invest (2004) 1.85
Whole-Exome sequencing identifies FAM20A mutations as a cause of amelogenesis imperfecta and gingival hyperplasia syndrome. Am J Hum Genet (2011) 1.84
Developmental expression analysis of the mouse and chick orthologues of IRF6: the gene mutated in Van der Woude syndrome. Dev Dyn (2006) 1.79
Therapeutic hypothermia preserves antioxidant defenses after severe traumatic brain injury in infants and children. Crit Care Med (2009) 1.70
Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice. J Clin Invest (2010) 1.67
Hereditary dentine disorders: dentinogenesis imperfecta and dentine dysplasia. Orphanet J Rare Dis (2008) 1.66
Treacher Collins syndrome: etiology, pathogenesis and prevention. Eur J Hum Genet (2008) 1.64
Mutation of the signal peptide region of the bicistronic gene DSPP affects translocation to the endoplasmic reticulum and results in defective dentine biomineralization. Hum Mol Genet (2002) 1.64
WD40 repeat propellers define a ubiquitin-binding domain that regulates turnover of F box proteins. Mol Cell (2010) 1.50
Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet (2011) 1.47
Localization and function of the brain excitatory amino acid transporter type 1 in cardiac mitochondria. J Mol Cell Cardiol (2004) 1.46
Integration of IRF6 and Jagged2 signalling is essential for controlling palatal adhesion and fusion competence. Hum Mol Genet (2009) 1.45
Mammary serine protease inhibitor (Maspin) binds directly to interferon regulatory factor 6: identification of a novel serpin partnership. J Biol Chem (2005) 1.44
Altered GABAergic function accompanies hippocampal degeneration in mice lacking ClC-3 voltage-gated chloride channels. Brain Res (2002) 1.44
A conserved Pbx-Wnt-p63-Irf6 regulatory module controls face morphogenesis by promoting epithelial apoptosis. Dev Cell (2011) 1.43
X-ray crystallographic studies on butyryl-ACP reveal flexibility of the structure around a putative acyl chain binding site. Structure (2002) 1.41
Enhanced ectodysplasin-A receptor (EDAR) signaling alters multiple fiber characteristics to produce the East Asian hair form. Hum Mutat (2008) 1.39
The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression. J Biol Chem (2003) 1.39
Prevalence and nonrandom distribution of exonic mutations in interferon regulatory factor 6 in 307 families with Van der Woude syndrome and 37 families with popliteal pterygium syndrome. Genet Med (2009) 1.38
Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta. J Cell Sci (2010) 1.36
Fibrillin microfibrils are stiff reinforcing fibres in compliant tissues. J Mol Biol (2003) 1.34
IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes. EMBO J (2011) 1.33
Facial clefting in Tp63 deficient mice results from altered Bmp4, Fgf8 and Shh signaling. Dev Biol (2008) 1.30
Fibrillin microfibrils. Adv Protein Chem (2005) 1.26
The Treacher Collins syndrome (TCOF1) gene product is involved in pre-rRNA methylation. Hum Mol Genet (2005) 1.25
Mutations in C4orf26, encoding a peptide with in vitro hydroxyapatite crystal nucleation and growth activity, cause amelogenesis imperfecta. Am J Hum Genet (2012) 1.24
Treacher Collins syndrome. Orthod Craniofac Res (2007) 1.22
Structure of monoubiquitinated PCNA and implications for translesion synthesis and DNA polymerase exchange. Nat Struct Mol Biol (2010) 1.21
Fibrillin-1 interactions with heparin. Implications for microfibril and elastic fiber assembly. J Biol Chem (2005) 1.19
Differential regulation of elastic fiber formation by fibulin-4 and -5. J Biol Chem (2009) 1.16
Homotypic fibrillin-1 interactions in microfibril assembly. J Biol Chem (2004) 1.15
The NMDA receptor NR1 C1 region bound to calmodulin: structural insights into functional differences between homologous domains. Structure (2007) 1.13
The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2. J Biol Chem (2010) 1.13
A cross-species analysis of Satb2 expression suggests deep conservation across vertebrate lineages. Dev Dyn (2010) 1.11
The personality of pathological gamblers: a meta-analysis. Clin Psychol Rev (2011) 1.10
The cell adhesion molecule nectin-1 is critical for normal enamel formation in mice. Hum Mol Genet (2008) 1.10
Comparative analysis of IRF6 variants in families with Van der Woude syndrome and popliteal pterygium syndrome using public whole-exome databases. Genet Med (2012) 1.10
Interferon regulatory factor 6 promotes differentiation of the periderm by activating expression of Grainyhead-like 3. J Invest Dermatol (2012) 1.09
Role of dimerization and substrate exclusion in the regulation of bone morphogenetic protein-1 and mammalian tolloid. Proc Natl Acad Sci U S A (2009) 1.09
Structural basis of phosphodiesterase 6 inhibition by the C-terminal region of the gamma-subunit. EMBO J (2009) 1.09
SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection. Am J Pathol (2013) 1.08
Wound complications after cleft repair in children with Van der Woude syndrome. J Craniofac Surg (2010) 1.07
Novel IRF6 mutations in Japanese patients with Van der Woude syndrome: two missense mutations (R45Q and P396S) and a 17-kb deletion. J Hum Genet (2003) 1.07
A mutation in the mouse Amelx tri-tyrosyl domain results in impaired secretion of amelogenin and phenocopies human X-linked amelogenesis imperfecta. Hum Mol Genet (2010) 1.07
Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am J Physiol Lung Cell Mol Physiol (2009) 1.06
Examination of a palatogenic gene program in zebrafish. Dev Dyn (2011) 1.06
The yeast Alix homolog Bro1 functions as a ubiquitin receptor for protein sorting into multivesicular endosomes. Dev Cell (2013) 1.05
Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin. Breast Cancer Res (2011) 1.05
Targeting of Rac GTPases blocks the spread of intact human breast cancer. Oncotarget (2012) 1.04
Solution X-ray scattering combined with computational modeling reveals multiple conformations of covalently bound ubiquitin on PCNA. Proc Natl Acad Sci U S A (2011) 1.04
Smad4-Irf6 genetic interaction and TGFβ-mediated IRF6 signaling cascade are crucial for palatal fusion in mice. Development (2013) 1.03
Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ. Nucleic Acids Res (2003) 1.03
Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein. Mol Cell Biol (2005) 1.03
Repression of transcription by WT1-BASP1 requires the myristoylation of BASP1 and the PIP2-dependent recruitment of histone deacetylase. Cell Rep (2012) 1.02
PLUNC: a multifunctional surfactant of the airways. Biochem Soc Trans (2011) 1.01
Mammalian neurogenesis requires Treacle-Plk1 for precise control of spindle orientation, mitotic progression, and maintenance of neural progenitor cells. PLoS Genet (2012) 1.01
Interferon regulatory factor 6 is necessary, but not sufficient, for keratinocyte differentiation. J Invest Dermatol (2011) 1.01
Maternal Interferon Regulatory Factor 6 is required for the differentiation of primary superficial epithelia in Danio and Xenopus embryos. Dev Biol (2008) 1.01
Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide. J Pharmacol Exp Ther (2002) 1.01
Exome sequence identifies RIPK4 as the Bartsocas-Papas syndrome locus. Am J Hum Genet (2011) 1.00
Novel, highly specific N-demethylases enable bacteria to live on caffeine and related purine alkaloids. J Bacteriol (2012) 0.99
Cytoskeletal protein filamin A is a nucleolar protein that suppresses ribosomal RNA gene transcription. Proc Natl Acad Sci U S A (2012) 0.99
Another face of the Treacher Collins syndrome (TCOF1) gene: identification of additional exons. Gene (2004) 0.98
Fibrillin: from microfibril assembly to biomechanical function. Philos Trans R Soc Lond B Biol Sci (2002) 0.97
MCS9.7 enhancer activity is highly, but not completely, associated with expression of Irf6 and p63. Dev Dyn (2011) 0.95
The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells. Mol Cancer (2010) 0.95
Van der Woude syndrome with sensorineural hearing loss, large craniofacial sinuses, dental pulp stones, and minor limb anomalies: report of a four-generation Thai family. Am J Med Genet (2002) 0.95
Secretion and cell volume regulation by salivary acinar cells from mice lacking expression of the Clcn3 Cl- channel gene. J Physiol (2002) 0.94
Crystal structure of SUMO-modified proliferating cell nuclear antigen. J Mol Biol (2010) 0.94
Disruption of SATB2 or its long-range cis-regulation by SOX9 causes a syndromic form of Pierre Robin sequence. Hum Mol Genet (2013) 0.94
Poloxamer 407-mediated alterations in the activities of enzymes regulating lipid metabolism in rats. J Pharm Pharm Sci (2003) 0.94
Identification of RTG2 as a modifier gene for CTG*CAG repeat instability in Saccharomyces cerevisiae. Genetics (2002) 0.92
Fibrillin-1 mutations causing Weill-Marchesani syndrome and acromicric and geleophysic dysplasias disrupt heparan sulfate interactions. PLoS One (2012) 0.92
Periderm prevents pathological epithelial adhesions during embryogenesis. J Clin Invest (2014) 0.91
Interaction between IRF6 and TGFA genes contribute to the risk of nonsyndromic cleft lip/palate. PLoS One (2012) 0.91
Collagen VI microfibril formation is abolished by an {alpha}2(VI) von Willebrand factor type A domain mutation in a patient with Ullrich congenital muscular dystrophy. J Biol Chem (2010) 0.91
Tropoelastin bridge region positions the cell-interactive C terminus and contributes to elastic fiber assembly. Proc Natl Acad Sci U S A (2012) 0.91
Balancing neural crest cell intrinsic processes with those of the microenvironment in Tcof1 haploinsufficient mice enables complete enteric nervous system formation. Hum Mol Genet (2012) 0.90
Marfan syndrome-causing mutations in fibrillin-1 result in gross morphological alterations and highlight the structural importance of the second hybrid domain. J Biol Chem (2006) 0.89
An etiologic regulatory mutation in IRF6 with loss- and gain-of-function effects. Hum Mol Genet (2014) 0.89
Defining elastic fiber interactions by molecular fishing: an affinity purification and mass spectrometry approach. Mol Cell Proteomics (2009) 0.89
A charged residue at the subunit interface of PCNA promotes trimer formation by destabilizing alternate subunit interactions. Acta Crystallogr D Biol Crystallogr (2009) 0.88